Clinical trial
Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function
NCT00195520 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195520 |
|---|---|
| Title | Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function |
| Official title | An Open Assessment of the Effect of Low-Dose Totelle® 1 mg on Menopausal Symptoms, Sexual Function and Quality of Life |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hot Flashes, Sleep Disorders |
| Intervention type | Drug |
| Interventions | Totelle® |
| Enrollment | 100 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Aug 5, 2008 |
| Countries | Brazil |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: